Choosing between tucatinib and T-DXd in HER2+ breast cancer VJOncology 1:46 2 years ago 554 Скачать Далее
HER2CLIMB-04: tucatinib plus T-DXd for HER2+ breast cancer VJOncology 1:16 3 years ago 291 Скачать Далее
HER2CLIMB-04: tucatinib + trastuzumab deruxtecan in HER2+ breast cancer VJOncology 1:12 3 years ago 171 Скачать Далее
DESTINY-Breast02: T-DXd in HER2+ metastatic breast cancer previously treated with T-DM1 VJOncology 1:08 1 year ago 159 Скачать Далее
Tucatinib for the Treatment of HER2+ Breast Cancer Targeted Oncology 4:30 4 years ago 1 127 Скачать Далее
HER2CLIMB: tucatinib efficacious against brain metastases in patients with HER2+ breast cancer VJOncology 1:11 3 years ago 183 Скачать Далее
HER2CLIMB: tucatinib in combination w/ capecitabine & trastuzumab VJOncology 2:01 4 years ago 238 Скачать Далее
Comparing and sequencing T-DM1 and T-DXd in HER2+ breast cancer VJOncology 0:58 2 months ago 85 Скачать Далее
TUXEDO-1: T-DXd for patients with HER2-positive breast cancer and brain metastasis VJOncology 0:53 2 years ago 320 Скачать Далее
Updated results of DESTINY-Breast03: T-DXd vs T-DM1 in metastatic HER2+ breast cancer VJOncology 1:20 1 year ago 623 Скачать Далее
HER2CLIMB-02: tucatinib + TDM-1 in advanced breast cancer VJOncology 3:15 3 years ago 1 393 Скачать Далее
Treatment strategies for HER2+ metastatic breast cancer VJOncology 2:15 2 years ago 224 Скачать Далее
Dr. Hamilton on the FDA Approval of Tucatinib in HER2+ Breast Cancer OncLive 1:10 4 years ago 935 Скачать Далее
Tucatinib & trastuzumab +/- chemo or pembrolizumab in unresectable or metastatic HER2+ GI cancers VJOncology 0:36 2 years ago 154 Скачать Далее
HER2CLIMB-02 Study Data Assesses Trastuzumab Plus Tucatinib in Patients With HER2+ Breast Cancer DocWire 12:41 7 months ago 283 Скачать Далее